Jane Street Group, LLC Clovis Oncology, Inc. Call Options Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

Call Options

18 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 17, 2022	BUY	$1.43 - $3.14 $248,105 - $544,790	173,500 Added 99.26%	348,300 $704,000
Q4 2021 Feb 15, 2022	BUY	$2.7 - $4.76 $77,220 - $136,136	28,600 Added 19.56%	174,800 $474,000
Q3 2021 Nov 16, 2021	SELL	$4.06 - $5.8 $616,713 - $881,020	-151,900 Reduced 50.96%	146,200 $652,000
Q2 2021 Aug 16, 2021	SELL	$5.02 - $7.05 $598,886 - $841,065	-119,300 Reduced 28.58%	298,100 $1.73 Million
Q1 2021 May 18, 2021	BUY	$4.81 - $10.34 $531,024 - $1.14 Million	110,400 Added 35.96%	417,400 $2.93 Million
Q4 2020 Feb 17, 2021	SELL	$4.13 - $6.41 $840,455 - $1.3 Million	-203,500 Reduced 39.86%	307,000 $1.47 Million
Q3 2020 Nov 17, 2020	SELL	$4.82 - $7.72 $297,876 - $477,096	-61,800 Reduced 10.8%	510,500 $2.98 Million
Q2 2020 Aug 17, 2020	SELL	$5.69 - $9.69 $85,919 - $146,319	-15,100 Reduced 2.57%	572,300 $3.86 Million
Q1 2020 May 15, 2020	BUY	$3.77 - $11.0 $1.21 Million - $3.52 Million	320,100 Added 119.75%	587,400 $3.74 Million
Q4 2019 Feb 14, 2020	BUY	$3.0 - $16.43 $755,400 - $4.14 Million	251,800 Added 1624.52%	267,300 $2.79 Million
Q3 2019 Nov 14, 2019	BUY	$3.93 - $15.35 $19,257 - $75,215	4,900 Added 46.23%	15,500 $61,000
Q1 2019 May 16, 2019	SELL	$17.66 - $30.28 $611,036 - $1.05 Million	-34,600 Reduced 76.55%	10,600 $263,000
Q4 2018 Feb 15, 2019	BUY	$11.63 - $32.67 $365,182 - $1.03 Million	31,400 Added 227.54%	45,200 $812,000
Q3 2018 Nov 14, 2018	SELL	$29.37 - $49.48 $217,338 - $366,152	-7,400 Reduced 34.91%	13,800 $405,000
Q2 2018 Aug 15, 2018	SELL	$42.06 - $62.4 $2.38 Million - $3.54 Million	-56,700 Reduced 72.79%	21,200 $964,000
Q1 2018 May 15, 2018	BUY	$50.12 - $67.72 $1.76 Million - $2.38 Million	35,100 Added 82.01%	77,900 $4.11 Million
Q4 2017 Feb 15, 2018	BUY	$57.69 - $84.58 $1.12 Million - $1.65 Million	19,500 Added 83.69%	42,800 $2.91 Million
Q3 2017 Nov 14, 2017	BUY	$67.17 - $84.81 $1.57 Million - $1.98 Million	23,300	23,300 $1.92 Million

Others Institutions Holding CLVS

# of Institutions

Shares Held

166

Call Options Held

Put Options Held

Exane Derivatives

166
Shares

$14
0.0% of portfolio

View Full List

About Clovis Oncology, Inc.

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

More about CLVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account